CA2617665C - Method for enantioselective hydrogenation of chromenes - Google Patents

Method for enantioselective hydrogenation of chromenes Download PDF

Info

Publication number
CA2617665C
CA2617665C CA2617665A CA2617665A CA2617665C CA 2617665 C CA2617665 C CA 2617665C CA 2617665 A CA2617665 A CA 2617665A CA 2617665 A CA2617665 A CA 2617665A CA 2617665 C CA2617665 C CA 2617665C
Authority
CA
Canada
Prior art keywords
phenyl
chromene
equol
chroman
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2617665A
Other languages
English (en)
French (fr)
Other versions
CA2617665A1 (en
Inventor
Kenneth David Reginald Setchell
Victor Dmitrievich Sorokin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Children's Hospital Medical Center
Ausio Pharmaceuticals LLC
Original Assignee
Cincinnati Children's Hospital Medical Center
Girindus America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Children's Hospital Medical Center, Girindus America Inc filed Critical Cincinnati Children's Hospital Medical Center
Publication of CA2617665A1 publication Critical patent/CA2617665A1/en
Application granted granted Critical
Publication of CA2617665C publication Critical patent/CA2617665C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
CA2617665A 2005-08-01 2006-08-01 Method for enantioselective hydrogenation of chromenes Expired - Fee Related CA2617665C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/194,280 2005-08-01
US11/194,280 US7528267B2 (en) 2005-08-01 2005-08-01 Method for enantioselective hydrogenation of chromenes
PCT/US2006/029589 WO2007016423A2 (en) 2005-08-01 2006-08-01 Method for enantioselective hydrogenation of chromenes

Publications (2)

Publication Number Publication Date
CA2617665A1 CA2617665A1 (en) 2007-02-08
CA2617665C true CA2617665C (en) 2014-12-02

Family

ID=37695254

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2617665A Expired - Fee Related CA2617665C (en) 2005-08-01 2006-08-01 Method for enantioselective hydrogenation of chromenes

Country Status (8)

Country Link
US (4) US7528267B2 (enExample)
EP (1) EP1919887B1 (enExample)
JP (1) JP5507081B2 (enExample)
CN (3) CN103755675B (enExample)
AU (1) AU2006275587B2 (enExample)
CA (1) CA2617665C (enExample)
DK (1) DK1919887T3 (enExample)
WO (1) WO2007016423A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1569636B1 (en) 2002-10-29 2017-12-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
GB0610804D0 (en) * 2006-05-31 2006-07-12 Portela & Ca Sa New crystal forms
US7714348B2 (en) * 2006-10-06 2010-05-11 Ac-Led Lighting, L.L.C. AC/DC light emitting diodes with integrated protection mechanism
TW201444815A (zh) * 2007-06-13 2014-12-01 大塚製藥股份有限公司 含雌馬酚（ｅｑｕｏｌ）之萃取物、其製造方法、雌馬酚萃取方法及含雌馬酚之食品（二）
JP2011506315A (ja) * 2007-12-05 2011-03-03 バイアル−ポルテラ アンド シーエー，エス．エー． 新たな塩、及び結晶形
EP2133080A1 (de) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
RU2364442C1 (ru) * 2008-06-30 2009-08-20 Государственное образовательное учреждение высшего профессионального образования "Тверской государственный технический университет" Способ приготовления модифицированного платинового катализатора для энантиоселективного гидрирования сложных эфиров альфа-кетокарбоновых кислот
EP2154133A1 (de) * 2008-08-14 2010-02-17 System Biologie AG Synthese von Equol
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US7875736B2 (en) * 2009-05-19 2011-01-25 Kaohsiung Medical University Intermediate compounds and processes for the preparation of 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran
US7875735B2 (en) * 2009-05-19 2011-01-25 Kaohsiung Medical University Processes for preparing isoflavonoids using 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran as a starting material
WO2011034126A1 (ja) * 2009-09-18 2011-03-24 不二製油株式会社 エクオールの不斉合成法
CN102633763B (zh) * 2012-04-11 2014-02-26 黑龙江大学 一种(s)-雌马酚的制备方法
ES2643407T3 (es) 2014-02-07 2017-11-22 Novogen Ltd. Compuestos de benzopirano funcionalizados y uso de los mismos
EP3191464B1 (en) * 2014-09-10 2019-11-06 System Biologie AG Synthesis of isoflavanes and intermediates thereof
US9914718B2 (en) * 2014-10-14 2018-03-13 Ausio Pharmaceuticals, Llc Anhydrous crystalline form of S-equol
JP6961694B2 (ja) 2016-07-26 2021-11-05 オージオ・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー Ｓ−エコールを用いてアルツハイマー病を診断するおよび治療する方法
US20190380998A1 (en) 2018-06-15 2019-12-19 The Board Of Regents Of The University Of Texas System Methods of treating and preventing melanoma with s-equol
AU2019285640A1 (en) 2018-06-15 2021-01-21 Board Of Regents Of The University Of Texas System Methods of treating and preventing breast cancer with S-equol
WO2020071818A1 (ko) * 2018-10-02 2020-04-09 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
KR102819124B1 (ko) * 2018-10-02 2025-06-12 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264509A (en) 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
GB8626344D0 (en) 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
KR20000057548A (ko) 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
WO1998039276A1 (en) * 1997-03-06 1998-09-11 Mitsui Chemicals Inc. Process for producing optically active amines
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
WO2001034612A2 (en) 1999-11-10 2001-05-17 The Penn State Research Foundation Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
SE9904850D0 (sv) 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
DE10044091A1 (de) * 2000-09-07 2002-04-04 Merck Patent Gmbh Chromanonderivate
EP1191030B1 (en) 2000-09-21 2005-05-04 Solvias AG Phosphinite-oxazolines and metal complexes
WO2003023056A2 (en) 2001-09-12 2003-03-20 F. Hoffmann-La Roche Ag Specific markers for multiple sclerosis
AU2003259220C1 (en) * 2002-07-24 2017-08-24 Australian Health & Nutrition Association Limited Compositions and products containing enantiomeric equol, and methods for their making
DE10237648A1 (de) 2002-08-13 2004-02-26 Behr Gmbh & Co. Wärmeübertrager
EP1569636B1 (en) 2002-10-29 2017-12-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
AU2002952453A0 (en) 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
EP1572186A2 (en) * 2002-12-19 2005-09-14 Pharmacia Corporation Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
ITMI20031354A1 (it) 2003-07-02 2005-01-03 Istituto Di Chimica Biomolecolare D El Cnr Sezione Sintesis enantioselettiva di composti enantiomericamente arricchiti.

Also Published As

Publication number Publication date
CN101535286B (zh) 2014-05-07
EP1919887B1 (en) 2015-02-18
DK1919887T3 (en) 2015-05-26
US20070027329A1 (en) 2007-02-01
CN103641808B (zh) 2016-04-20
CN101535286A (zh) 2009-09-16
WO2007016423A2 (en) 2007-02-08
US20100069653A1 (en) 2010-03-18
WO2007016423A3 (en) 2009-04-30
JP5507081B2 (ja) 2014-05-28
US20120004427A1 (en) 2012-01-05
CN103641808A (zh) 2014-03-19
JP2009503079A (ja) 2009-01-29
US8263790B2 (en) 2012-09-11
CA2617665A1 (en) 2007-02-08
US7960573B2 (en) 2011-06-14
US8716497B2 (en) 2014-05-06
US20130116450A1 (en) 2013-05-09
AU2006275587B2 (en) 2012-09-13
EP1919887A2 (en) 2008-05-14
EP1919887A4 (en) 2011-01-19
CN103755675B (zh) 2015-11-18
AU2006275587A1 (en) 2007-02-08
US7528267B2 (en) 2009-05-05
CN103755675A (zh) 2014-04-30

Similar Documents

Publication Publication Date Title
US7960573B2 (en) Method for enantioselective hydrogenation of chromenes
US7906660B2 (en) Production of isoflavone derivatives
US6384225B1 (en) Intermediates in the preparation of substituted chroman derivatives
ZA200305684B (en) 2H-1-Benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof.
Page et al. Asymmetric epoxidation of chromenes mediated by iminium salts: Synthesis of mollugin and (3S, 4R)-trans-3, 4-dihydroxy-3, 4-dihydromollugin
KR102514781B1 (ko) 이소플라반 및 이의 중간체의 합성
AU2004200117B2 (en) Production of isoflavone derivatives
Malik Total synthesis of natural product pterocarpans useful as selective estrogen receptor modulators
CN105358540A (zh) 在脲或硫脲的存在下使用手性吡咯烷来形成手性4-苯并二氢吡喃酮
MXPA01008233A (es) Produccion de derivados de isoflavona

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220301

MKLA Lapsed

Effective date: 20200831